Allergy Therapeutics (AGY.LSE) Q4 2025 Earnings

11DecConfirmed
Q4 2024
Q1 2025
Q3 2025
Q4 2025
-0.53
-0.43
-0.33
-0.22

Details

Expected EPS
N/A
Actual EPS
-0.53305769088
Surprise EPS
-0.53
Surprise Percent
+∞%

Description

Allergy Therapeutics (AGY.LSE) has reported earnings of -0.53305769088 per share for Q4 2025.

0 Comments

Share your thoughts